Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-26

Clinical Trial Update: Role of Pancreatic Triglyceride Content in Beta-cell Function

View source ↗

Summary

A completed clinical trial investigating how pancreatic triglyceride content affects beta-cell function in obesity and type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Obesity, Type 2 Diabetes | Status: COMPLETED | Results posted: 2017-12-26